does semaglutide help stop drinking cuts alcohol cravings but not daily drinks in Phase II trial GLP-1 medications: The next big

Patient Safety Continuing appetite-suppressing medication at very low BMIs may increase the risk of: Excessive or unintended weight loss Nutritional deficiencies Lean muscle loss Hormonal disruption Disordered eating patterns The BMI 22 kg/m threshold acts as a safety boundary

Mol Metab 2022

All IV Infusion treatments will take approximately 45-60 minutes

The typical maintenance dose for a patient without neurological symptoms is a 1mg injection every two to three months for life

If you've spent any time in my Histamine and MCAS guide, you already know mast cells are the spark plug behind reactive skin, hives, rosacea, eczema, and the random cheek-flushing that hits after a glass of wine